Vaccinia-Virus-Based Vaccines Are Expected to Elicit Highly Cross-Reactive Immunity to the 2022 Monkeypox Virus
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vaccinia-Virus-Based Vaccines Are Expected to Elicit Highly Cross-Reactive Immunity to the 2022 Monkeypox Virus
Authors
Keywords
-
Journal
Viruses-Basel
Volume 14, Issue 9, Pages 1960
Publisher
MDPI AG
Online
2022-09-09
DOI
10.3390/v14091960
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The changing epidemiology of human monkeypox—A potential threat? A systematic review
- (2022) Eveline M. Bunge et al. PLoS Neglected Tropical Diseases
- Identification of Potential SARS-CoV-2 CD8+ T Cell Escape Mutants
- (2022) Syed Faraz Ahmed et al. Vaccines
- A randomized phase II trial to compare safety and immunogenicity of the MVA-BN smallpox vaccine at various doses in adults with a history of AIDS
- (2020) Edgar Turner Overton et al. VACCINE
- Deconvolving mutational patterns of poliovirus outbreaks reveals its intrinsic fitness landscape
- (2020) Ahmed A. Quadeer et al. Nature Communications
- Genes that control vaccinia virus immunogenicity
- (2020) Sergey Shchelkunov et al. Acta Naturae
- COVIDep: a web-based platform for real-time reporting of vaccine target recommendations for SARS-CoV-2
- (2020) Syed Faraz Ahmed et al. Nature Protocols
- Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes
- (2020) Asaf Poran et al. Genome Medicine
- Cross-serotypically conserved epitope recommendations for a universal T cell-based dengue vaccine
- (2020) Syed Faraz Ahmed et al. PLoS Neglected Tropical Diseases
- MPL resolves genetic linkage in fitness inference from complex evolutionary histories
- (2020) Muhammad Saqib Sohail et al. NATURE BIOTECHNOLOGY
- Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox
- (2019) Phillip R. Pittman et al. NEW ENGLAND JOURNAL OF MEDICINE
- A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy
- (2019) Ellen M. Beer et al. PLoS Neglected Tropical Diseases
- The Immune Epitope Database (IEDB): 2018 update
- (2018) Randi Vita et al. NUCLEIC ACIDS RESEARCH
- Structure–function characterization of three human antibodies targeting the vaccinia virus adhesion molecule D8
- (2017) Michael H. Matho et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8+ T cells
- (2017) Jinsheng Wen et al. Nature Microbiology
- Assessment of the Protective Effect of Imvamune and Acam2000 Vaccines against Aerosolized Monkeypox Virus in Cynomolgus Macaques
- (2013) G. J. Hatch et al. JOURNAL OF VIROLOGY
- MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability
- (2013) K. Katoh et al. MOLECULAR BIOLOGY AND EVOLUTION
- Outbreaks of human monkeypox after cessation of smallpox vaccination
- (2012) Mary G. Reynolds et al. TRENDS IN MICROBIOLOGY
- Smallpox vaccines: targets of protective immunity
- (2010) Bernard Moss IMMUNOLOGICAL REVIEWS
- Using Time-Structured Data to Estimate Evolutionary Rates of Double-Stranded DNA Viruses
- (2010) C. Firth et al. MOLECULAR BIOLOGY AND EVOLUTION
- ACAM2000™: The new smallpox vaccine for United States Strategic National Stockpile
- (2010) Aysegul Nalca et al. Drug Design Development and Therapy
- Evaluation of smallpox vaccines using variola neutralization
- (2009) I. K. Damon et al. JOURNAL OF GENERAL VIROLOGY
- IMVAMUNE®: modified vaccinia Ankara strain as an attenuated smallpox vaccine
- (2008) Jeffrey S Kennedy et al. Expert Review of Vaccines
- Vaccination of BALB/c Mice with Escherichia coli-Expressed Vaccinia Virus Proteins A27L, B5R, and D8L Protects Mice from Lethal Vaccinia Virus Challenge
- (2008) A. Berhanu et al. JOURNAL OF VIROLOGY
- Differential Antigen Requirements for Protection against Systemic and Intranasal Vaccinia Virus Challenges in Mice
- (2008) D. R. Kaufman et al. JOURNAL OF VIROLOGY
- Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax® in healthy vaccinia-naive adults
- (2008) Sharon E. Frey et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now